Labs with a Buy rating and $15 price target. The analyst likes how the company is creating a "one-stop-shop" for lifestyle and wellness solutions that include physician consultations, prescriptions and over the counter products. He believes Conversion's business is gaining "very significant momentum" and that ultimately a larger strategic entity may seek to acquire the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.